Low prevalence of influenza A strains with resistance markers in Brazil during 2017–2019 seasons

Low prevalence of influenza A strains with resistance markers in Brazil during 2017–2019 seasons

The influenza A virus (IAV) is of a major public health concern as it causes annual epidemics and has the potential to cause pandemics. At present, the neuraminidase inhibitors (NAIs) are the most widely used anti-influenza drugs, but, more recently, the drug baloxavir marboxil (BXM), a polymerase i...

Full description

Bibliographic Details
Main Authors: Thiago das Chagas Sousa, Jessica Santa Cruz Carvalho Martins, Milene Dias Miranda, Cristiana Couto Garcia, Paola Cristina Resende, Cliomar A. Santos, Maria do Carmo Debur, Rodrigo Ribeiro Rodrigues, Andrea Cony Cavalcanti, Tatiana Schäffer Gregianini, Felipe Campos de Melo Iani, Felicidade Mota Pereira, Sandra Bianchini Fernandes, Jessylene de Almeida Ferreira, Katia Correa de Oliveira Santos, Fernando Motta, David Brown, Walquiria Aparecida Ferreira de Almeida, Marilda Mendonça Siqueira, Aline da Rocha Matos
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-09-01
Series:Frontiers in Public Health
Subjects:
influenza A virus
resistance
neuraminidase (NA) inhibitors
oseltamivir
baloxavir marboxil
adamantane
Online Access:https://www.frontiersin.org/articles/10.3389/fpubh.2022.944277/full

Internet

https://www.frontiersin.org/articles/10.3389/fpubh.2022.944277/full

Similar Items